Go to deals
Financial Services

Duke Capital Limited has completed a fundraising

Duke Capital Limited has completed a successful fundraise, securing US$29.8 million (£23.5 million) through a placing and retail offer on the Alternative Investment Market (AIM). This milestone will further enable Duke Capital to continue its innovative approach to alternative financing solutions for small and medium enterprises (SMEs) across the UK and Europe.

Duke Capital delivers hybrid capital solutions to SME business owners in the UK, Europe and North America, combining the best features of both equity and debt. Since 2017, Duke Capital has provided unique long-term financing which eliminates refinancing risk and the need for a short-term exit. This is achieved through a distinctive “corporate mortgage,” while also aligning its returns to grow with the success of the business.

Oaklins Cavendish, one of Oaklins’ member firms in the UK, supported Duke Capital in this recent fundraise.

Talk to the deal team

Geoff Nash

Director
London, United Kingdom
Oaklins Cavendish

Related deals

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Healthcare

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.

Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.

Learn more
Microfinanciera Fundeser has been sold to Grupo Financiero Atlántida
Private Equity | Financial Services

Microfinanciera Fundeser has been sold to Grupo Financiero Atlántida

Incofin has successfully exited its investment in Microfinanciera Fundeser in Nicaragua through two of its funds: Rural Impulse Fund II (RIF II) and agRIF. It has sold 100% of its stake in Microfinanciera Fundeser to Grupo Financiero Atlántida through its subsidiary, Inversiones Tres Lagos.

Learn more
doValue has finalized a rights issue
Financial Services

doValue has finalized a rights issue

doValue has successfully completed a rights issue. The capital increase was implemented to finance doValue’s acquisition of Gardant.

Learn more